GoodRx Holdings (GDRX) Stock Forecast for 2025, 2026, 2027. Sell or Buy Prediction







Features of exchanging USDC ERC20 to Bank Transfer

March 12, 2025 Features of exchanging USDC ERC20 to Bank Transfer

You can use electronic exchange services if you need to exchange the digital asset USDC ERC20 to Bank Transfer. It is not recommended…
Why Stock Caps Matter When Building a Diversified Portfolio

February 19, 2025 Why Stock Caps Matter When Building a Diversified Portfolio

Most investors who want to expand their investment options put their money in different asset types and industries across many areas in the…
Top 5 Coins for the Maximum Passive Income from Staking by 2024

February 5, 2025 Top 5 Coins for the Maximum Passive Income from Staking by 2024

Staking is one of the ways that is now being used as a secure and profitable way to earn money without doing anything…
Trading Stocks With AI: A Modern Approach

January 21, 2025 Trading Stocks With AI: A Modern Approach

The stock market can feel overwhelming, especially with its constant ups and downs. Trading stocks with AI is revolutionizing how investors analyze trends,…
Bitcoin Is Great, but Here Are 3 Altcoins Worth Considering in 2025

January 21, 2025 Bitcoin Is Great, but Here Are 3 Altcoins Worth Considering in 2025

The launch of spot Bitcoin (CRYPTO: BTC) exchange-traded funds (ETFs) in January 2025 marked a turning point in the cryptocurrency market. These ETFs…

GoodRx Holdings (GDRX) Stock Forecast for 2025, 2026, 2027. Sell or Buy?

Updated: April 20, 2025 (13:33)

Sector: Healthcare

The share price of GoodRx Holdings, Inc. (GDRX) now

Latest session on the 17th of April for
GoodRx Holdings, Inc. is positive
Trading Volume: 545789
Open: 4.45 /  High: 4.49 /  Low: 4.39
Current value: $4.485
What analysts predict: $6.62
52-week High/Low: $9.26 / $3.82
50-Day Moving Average: $4.641 — resistance level today
200-Day Moving Average: $5.92 — resistance level today

Are you interested in GoodRx Holdings, Inc. stocks and want to buy them, or are they already in your portfolio? If yes, then on this page you will find useful information about the dynamics of the GoodRx Holdings stock price in 2025, 2026, 2027. How much will one GoodRx Holdings share be worth in 2025 - 2027?

When should I take profit in GoodRx Holdings stock? When should I record a loss on GoodRx Holdings stock? What are analysts' forecasts for GoodRx Holdings stock? What is the future of GoodRx Holdings stock? We forecast GoodRx Holdings stock performance using neural networks based on historical data on GoodRx Holdings stocks. Also, when forecasting, technical analysis tools are used, world geopolitical and news factors are taken into account.

GoodRx Holdings stock prediction results are shown below and presented in the form of graphs, tables and text information, divided into time intervals. (Next month, 2025, 2026, 2027, and ) The final quotes of the instrument at the close of the previous trading day are a signal to adjust the forecasts for GoodRx Holdings shares. This happens once a day.


Historical and forecast chart of GoodRx Holdings stock

The chart below shows the historical price of GoodRx Holdings stock and a prediction chart for the next month. For convenience, prices are divided by color. Forecast prices include: Optimistic Forecast, Pessimistic Forecast, and Weighted Average Best Forecast. Detailed values for the GoodRx Holdings stock price can be found in the table below.

Long-term forecasts by years.

GoodRx Holdings IPO will take place on September 22, 2020. The company is a developer of a platform that collects various data from 70 thousand pharmacies and compares drug prices to find cheaper ones. The placement underwriters are Morgan Stanley, Goldman Sachs, J.P. Morgan and Barclays.

ABOUT IPO, SHAREHOLDERS AND PURCHASE OF GOODRX

Among the company’s shareholders are Silver Lake with a 35.3% stake (33.8% after the IPO), Francisco Partners with a 23.7% stake (22.1% after the IPO), Spectrum with a 15.4% stake (12 , 5% after the IPO) and Idea Men with a share of 17.9 %% (15.6% after the IPO). Silver Lake will IPO $ 100 million in Class A shares in a private placement that will take place concurrently with the IPO. In total, the company is placing 34.615 million shares, of which 23.4 million shares are sold by the company itself and 11.192 million – by the company’s shareholders. Throughout its history, the company has made two acquisitions – Iodine (a company that helps patients select the right drugs) in January 2017 and HeyDoctor (a telemedicine provider) in September 2019.

Trending Themes in the Healthcare Sector

GoodRx Holdings daily forecast for a month

Date Target Pes. Opt. Vol., %
Apr 22 4.59 4.56 4.63 1.63
Apr 23 4.55 4.53 4.59 1.23
Apr 24 4.56 4.50 4.61 2.47
Apr 25 4.57 4.52 4.60 1.78
Apr 26 4.58 4.53 4.61 1.68
Apr 27 4.63 4.60 4.66 1.21
Apr 28 4.60 4.56 4.66 2.34
Apr 29 4.56 4.50 4.60 2.03
Apr 30 4.57 4.54 4.63 2.07
May 01 4.49 4.42 4.52 2.28
May 02 4.43 4.40 4.48 1.85
May 03 4.42 4.37 4.49 2.65
May 04 4.43 4.39 4.49 2.20
May 05 4.43 4.41 4.48 1.49
May 06 4.50 4.46 4.52 1.25
May 07 4.53 4.49 4.59 2.24
May 08 4.61 4.59 4.65 1.49
May 09 4.65 4.59 4.69 2.19
May 10 4.62 4.60 4.64 0.96
May 11 4.54 4.52 4.58 1.45
May 12 4.53 4.48 4.58 2.16
May 13 4.50 4.45 4.54 1.98
May 14 4.59 4.51 4.63 2.60
May 15 4.58 4.53 4.63 2.25
May 16 4.67 4.62 4.71 1.92
May 17 4.71 4.64 4.73 1.85
May 18 4.71 4.69 4.78 1.95
May 19 4.67 4.60 4.74 3.15
May 20 4.59 4.55 4.61 1.45
May 21 4.54 4.51 4.58 1.53

GoodRx Holdings Daily Price Targets


GoodRx Holdings Stock Forecast 04-22-2025.

Forecast target price for 04-22-2025: $4.59.
Positive dynamics for GoodRx Holdings shares will prevail with possible volatility of 1.605%.
Pessimistic target level: 4.56
Optimistic target level: 4.63

GoodRx Holdings Stock Forecast 04-23-2025.

Forecast target price for 04-23-2025: $4.55.
Negative dynamics for GoodRx Holdings shares will prevail with possible volatility of 1.211%.
Pessimistic target level: 4.53
Optimistic target level: 4.59

GoodRx Holdings Stock Forecast 04-24-2025.

Forecast target price for 04-24-2025: $4.56.
Positive dynamics for GoodRx Holdings shares will prevail with possible volatility of 2.412%.
Pessimistic target level: 4.50
Optimistic target level: 4.61

GoodRx Holdings Stock Forecast 04-25-2025.

Forecast target price for 04-25-2025: $4.57.
Positive dynamics for GoodRx Holdings shares will prevail with possible volatility of 1.750%.
Pessimistic target level: 4.52
Optimistic target level: 4.60

GoodRx Holdings Stock Forecast 04-26-2025.

Forecast target price for 04-26-2025: $4.58.
Positive dynamics for GoodRx Holdings shares will prevail with possible volatility of 1.652%.
Pessimistic target level: 4.53
Optimistic target level: 4.61

GoodRx Holdings Stock Forecast 04-27-2025.

Forecast target price for 04-27-2025: $4.63.
Positive dynamics for GoodRx Holdings shares will prevail with possible volatility of 1.193%.
Pessimistic target level: 4.60
Optimistic target level: 4.66

GDRX (GDRX) Monthly Stock Prediction for 2025

Month Target Pes. Opt. Vol., %
May. 5.01 4.83 5.15 6.18
Jun. 5.55 5.12 5.76 11.09
Jul. 5.47 5.11 5.91 13.65
Aug. 5.72 5.42 5.90 8.15
Sep. 5.49 5.20 5.89 11.74
Oct. 5.18 4.93 5.44 9.48
Nov. 5.60 5.35 5.76 7.12
Dec. 5.61 5.38 5.85 8.06

GoodRx Holdings forecast for this year


GoodRx Holdings Stock Prediction for May 2025

An uptrend is forecast for this month with an optimal target price of $5.00705. Pessimistic: $4.83. Optimistic: $5.15


GoodRx Holdings Stock Prediction for Jun 2025

An uptrend is forecast for this month with an optimal target price of $5.54782. Pessimistic: $5.12. Optimistic: $5.76


GoodRx Holdings Stock Prediction for Jul 2025

An downtrend is forecast for this month with an optimal target price of $5.46793. Pessimistic: $5.11. Optimistic: $5.91


GoodRx Holdings Stock Prediction for Aug 2025

An uptrend is forecast for this month with an optimal target price of $5.71726. Pessimistic: $5.42. Optimistic: $5.90


GoodRx Holdings Stock Prediction for Sep 2025

An downtrend is forecast for this month with an optimal target price of $5.49086. Pessimistic: $5.20. Optimistic: $5.89


GoodRx Holdings Stock Prediction for Oct 2025

An downtrend is forecast for this month with an optimal target price of $5.18118. Pessimistic: $4.93. Optimistic: $5.44


GoodRx Holdings Stock Prediction for Nov 2025

An uptrend is forecast for this month with an optimal target price of $5.59774. Pessimistic: $5.35. Optimistic: $5.76


GoodRx Holdings Stock Prediction for Dec 2025

An uptrend is forecast for this month with an optimal target price of $5.61118. Pessimistic: $5.38. Optimistic: $5.85



GoodRx Holdings (GDRX) Monthly Stock Prediction for 2026

Month Target Pes. Opt. Vol., %
Jan 5.32 5.07 5.52 8.10
Feb 5.33 5.14 5.59 8.01
Mar 5.55 5.22 5.94 12.12
Apr 5.76 5.28 6.06 12.78
May 6.08 5.90 6.45 8.49
Jun 5.81 5.60 6.02 6.94
Jul 6.04 5.51 6.58 16.20
Aug 5.72 5.23 5.94 11.92
Sep 6.36 6.16 6.61 6.92
Oct 6.43 6.21 6.78 8.43
Nov 6.29 5.95 6.54 8.99
Dec 6.10 5.62 6.32 11.00

GoodRx Holdings (GDRX) Monthly Stock Prediction for 2027

Month Target Pes. Opt. Vol., %
Jan 5.77 5.55 6.31 11.97
Feb 5.46 5.30 5.75 7.86
Mar 5.56 5.37 6.07 11.55
Apr 6.15 5.85 6.35 7.79
May 6.80 6.22 7.03 11.61
Jun 6.49 5.96 7.02 15.09
Jul 6.79 6.51 7.16 8.99
Aug 6.33 5.75 6.50 11.57
Sep 6.52 6.13 6.81 9.89
Oct 6.51 6.27 6.70 6.41
Nov 5.81 5.58 6.25 10.82
Dec 6.30 5.95 6.67 10.77

GoodRx Holdings information and performance

GoodRx Holdings Address

233 WILSHIRE BLVD., SUITE 990, SANTA MONICA, CA, US

Market Capitalization: 1 720 491 000 $

Market capitalization of the GoodRx Holdings, Inc. is the total market value of all issued shares of a company. It is calculated by the formula multiplying the number of GDRX shares in the company outstanding by the market price of one share.

EBITDA: 99 541 000 $

EBITDA of GoodRx Holdings is earnings before interest, income tax and depreciation of assets.

PE Ratio: 112.12

P/E ratio (price to earnings) - shows the ratio between the price of a share and the company's profit

PEG Ratio: None

Price/earnings to growth

DPS: None

Dividend Per Share is a financial indicator equal to the ratio of the company's net profit available for distribution to the annual average of ordinary shares.

DY: None

Dividend yield is a ratio that shows how much a company pays in dividends each year at the stock price.

EPS: 0.04

EPS shows how much of the net profit is accounted for by the common share.

Quarterly Earnings Growth YOY: -0.873
Quarterly Revenue Growth YOY: 0.01
Trailing PE: 112.12

Trailing P/E depends on what has already been done. It uses the current share price and divides it by the total earnings per share for the last 12 months.

Forward PE: 10.6

Forward P/E uses projections of future earnings instead of final numbers.

EV To Revenue: 2.291

Enterprise Value (EV) /Revenue

EV To EBITDA: 11.8

The EV / EBITDA ratio shows the ratio of the cost (EV) to its profit before tax, interest and amortization (EBITDA).

Shares Outstanding: 106740000

Number of issued ordinary shares

Shares Float: N/A

Number of freely tradable shares

Shares Short Prior Month: N/A

Shares Short Prior Month - the number of shares in short positions in the last month.

Short Ratio: N/A
Percent Insiders: N/A
Percent Institutions: N/A

FAQ (Frequently Asked Questions about GoodRx Holdings Stock)

Should I Buy GoodRx Holdings Shares in 2025 year?

The maximum forecasted share price for next year is $6.43, which is $1.95 higher than the current stock price. By investing in GoodRx Holdings shares today for a one-year period, you could achieve a profit of 43.40%. With an investment horizon of up to two years, the target share price is $6.80. resulting in a profit of 51.71% ($2.32 per share).

Does GoodRx Holdings pay dividends?

No, it does not

Which economic sector do GoodRx Holdings's shares belong to?

GoodRx Holdings's shares belong to the "Healthcare" sector of economic.

Which other securities belong to the same sector as GoodRx Holdings's shares?

You can view all the stocks that are part of the same sector as GoodRx Holdings's shares in the Healthcare section.


Related stocks from Healthcare sector


Disclaimer:

All forecast data on the site are provided for informational purposes of using neural forecasting tools in the financial market and are not a call to action and, moreover, are not trading signals. When using the forecast data, the investor assumes all financial risks. The pandaforecast.com portal is not responsible for the loss of your money in the stock market as a result of using the information contained on the site.